Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$561M |
| 2 |
Citizens Financial Group
CFG
|
+$465M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$462M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$439M |
| 5 |
WEC Energy
WEC
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$1.33B |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1B |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$968M |
| 4 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$740M |
| 5 |
Wells Fargo
WFC
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.24% |
| 2 | Financials | 14.23% |
| 3 | Technology | 13.63% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $1.42M | ﹤0.01% |
17,815
+1,201
| +7% | +$96K |
|
3552
Crown Crafts
CRWS
$32M
| $1.42M | ﹤0.01% |
177,062
+1,513
| +0.9% | +$12.3K |
|
3553
BlueLinx
BXC
$502M
| $1.42M | ﹤0.01% |
147,460
+398
| +0.3% | +$4.38K |
|
3554
Apple Hospitality REIT
APLE
$3.91B
| $1.41M | ﹤0.01% |
+74,810
| New | +$1.4M |
|
|
FFWM
3555
DELISTED
First Foundation Inc
FFWM
| $1.41M | ﹤0.01% |
142,582
+5,722
| +4% | +$54.3K |
|
|
LNBB
3556
DELISTED
L N B BANCORP INC
LNBB
| $1.41M | ﹤0.01% |
76,042
+1,331
| +2% | +$24.1K |
|
3557
Chemung Financial Corp
CHMG
$397M
| $1.39M | ﹤0.01% |
52,449
+310
| +0.6% | +$8.25K |
|
3558
Brown-Forman Class A
BF.A
$13.2B
| $1.38M | ﹤0.01% |
+31,023
| New | +$1.24M |
|
|
ERN
3559
DELISTED
Erin Energy Corp
ERN
| $1.38M | ﹤0.01% |
352,288
-119,549
| -25% | -$666K |
|
|
GFN
3560
DELISTED
General Finance Corporation
GFN
| $1.38M | ﹤0.01% |
263,575
-10,729
| -4% | -$71.6K |
|
|
CBMG
3561
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $1.37M | ﹤0.01% |
36,435
+27,824
| +323% | +$898K |
|
3562
Innovative Solutions & Support
ISSC
$375M
| $1.36M | ﹤0.01% |
413,838
-1,545
| -0.4% | -$5.48K |
|
3563
Evolent Health
EVH
$350M
| $1.36M | ﹤0.01% |
+69,930
| New | +$1.3M |
|
3564
Astrotech Corp
ASTC
$14.5M
| $1.36M | ﹤0.01% |
3,344
+33
| +1% | +$14.5K |
|
|
ICAD
3565
DELISTED
iCAD Inc
ICAD
| $1.36M | ﹤0.01% |
419,053
+2,999
| +0.7% | +$19.1K |
|
|
OCRX
3566
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.36M | ﹤0.01% |
357,253
+12,960
| +4% | +$49.7K |
|
3567
Imunon
IMNN
$7.02M
| $1.35M | ﹤0.01% |
211
+16
| +8% | +$114K |
|
|
VRNG
3568
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
| $1.34M | ﹤0.01% |
241,365
+6,995
| +3% | +$45.4K |
|
3569
Cineverse
CNVS
$63.5M
| $1.33M | ﹤0.01% |
9,468
-395
| -4% | -$78.4K |
|
3570
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $1.33M | ﹤0.01% |
18,964
+8,950
| +89% | +$642K |
|
|
PTN
3571
Palatin Technologies
PTN
$14.3M
| $1.32M | ﹤0.01% |
1,189
+16
| +1% | +$19.2K |
|
3572
Lincoln Educational Services
LINC
$1.37B
| $1.32M | ﹤0.01% |
652,076
+17,485
| +3% | +$39.7K |
|
3573
Veru
VERU
$38M
| $1.32M | ﹤0.01% |
73,121
-555
| -0.8% | -$14.8K |
|
|
WBB
3574
DELISTED
Westbury Bancorp, Inc.
WBB
| $1.31M | ﹤0.01% |
75,846
| – | – |
|
|
VBTX
3575
DELISTED
Veritex Holdings
VBTX
| $1.3M | ﹤0.01% |
+87,378
| New | +$1.26M |
|
Similar funds
Vanguard Group's Q2 2015 Portfolio in Review
As of Q2 2015, Vanguard Group held 4,259 positions worth $1.48T, up 0.33% from $1.47T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 4%. Vanguard Group opened 105 new positions and exited 67, leaving the 4,259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- Vanguard Group's largest Q2 2015 buy was Uniti Group: 7,979,038 shares worth $197M.
- Vanguard Group added most to AbbVie in Q2 2015, an estimated $561M increase.
- Vanguard Group's biggest Q2 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $968M.
- Vanguard Group fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $1.33B.
- Vanguard Group's ten largest holdings make up 13% of its $1.48T portfolio in Q2 2015.
- Vanguard Group opened 105 new positions and closed 67 in Q2 2015.
- Vanguard Group's portfolio value rose 0.33% quarter-over-quarter to $1.48T.
Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.